The (US) National Academy of Sciences Registry of aging twin veterans contains 15,924 pairs of white male twins born between 1917 and 1927. About 8,000 pairs are living today. In preparation for a study of Alzheimer's disease (AD) in this Registry, we investigated 829 members of pairs living in North and South Carolina, Virginia, in the District of Columbia, and Maryland. A brief telephone interview for cognitive symptoms was administered to 678 (91.4%) of 742 subjects located. Cognitive dysfunction was identified initially in 124 individuals (18.3%), whose clinical histories were then obtained over the telephone. Results suggested that 108 subjects did not have AD. Ten (62.5%) of the remaining 16 subjects underwent diagnostic evaluation for dementia. One had cerebrovascular disease with coincident depression. Two others with probable AD were a monozygotic (MZ) pair. The remaining 7 subjects had possible AD or a mild but progressive cognitive disorder suggestive of early AD. Upon subsequent examination, 3 of 4 MZ co-twins showed significant symptoms that had not been detected during screening procedures. None of 3 dizygotic co-twin showed any significant abnormality. These results suggest: (1) that a combination of mailed information, telephone interviews, and clinical examination provides a feasible means of detecting AD in the Registry, (2) that about 150 pairs with presumptive AD in 1 or both subjects will be identified in a full study of the Registry; (3) that concordance for AD in MZ pairs may exceed prior estimates, but (4) that such rates of concordance are apparent only upon detailed evaluation of apparently normal co-twins as well as their impaired brothers. Longitudinal observation of pairs with apparently affected individuals will be required for definitive conclusions.

Keywords:
Alzheimer's disease, Twin studies, Telephone interview, Cognitive symptoms, prevalence, Concordance
This content is only available via PDF.
© 1990 S. Karger AG, Basel
1990
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.